title: The MIF-173G/C polymorphism does not contribute to prednisone poor response in vivo in childhood acute lymphoblastic leukemia.
authors.forename: O
authors.initials: O
authors.lastname: Ziino
authors.forename: L E
authors.initials: LE
authors.lastname: D'Urbano
authors.forename: F
authors.initials: F
authors.lastname: De Benedetti
authors.forename: V
authors.initials: V
authors.lastname: Conter
authors.forename: E
authors.initials: E
authors.lastname: Barisone
authors.forename: G
authors.initials: G
authors.lastname: De Rossi
authors.forename: G
authors.initials: G
authors.lastname: Basso
authors.forename: M
authors.initials: M
authors.lastname: Aricò
mesh_terms: D016022:Case-Control Studies; D019008:Drug Resistance, Neoplasm / Q000235:genetics*; D005787:Gene Frequency; D005838:Genotype; D006801:Humans; D008263:Macrophage Migration-Inhibitory Factors / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy / Q000235:genetics*; D011241:Prednisone / Q000494:pharmacology*
chemical_list: D008263:Macrophage Migration-Inhibitory Factors; D011241:Prednisone